205 related articles for article (PubMed ID: 19187116)
1. Expressions of p53, cyclinD1 and histopathological features in basal cell carcinomas.
Koseoglu RD; Sezer E; Eyibilen A; Aladag I; Etikan I
J Cutan Pathol; 2009 Sep; 36(9):958-65. PubMed ID: 19187116
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
[TBL] [Abstract][Full Text] [Related]
3. [Immunomorphological features of cutaneous basal-cell carcinoma].
Chuprov IN
Vopr Onkol; 2008; 54(6):715-9. PubMed ID: 19241845
[TBL] [Abstract][Full Text] [Related]
4. [A study on expressions of P53 protein and proliferating cell nuclear antigen in malignant eyelid tumors].
Niu Y; Wang H; Ji J; Lin H; Zhang A
Zhonghua Yan Ke Za Zhi; 1999 Jan; 35(1):36-9, 5. PubMed ID: 11835772
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin.
Son KD; Kim TJ; Lee YS; Park GS; Han KT; Lim JS; Kang CS
J Surg Oncol; 2008 Jun; 97(7):615-20. PubMed ID: 18404670
[TBL] [Abstract][Full Text] [Related]
6. P16 is overexpressed in cutaneous carcinomas located on sun-exposed areas.
Conscience I; Jovenin N; Coissard C; Lorenzato M; Durlach A; Grange F; Birembaut P; Clavel C; Bernard P
Eur J Dermatol; 2006; 16(5):518-22. PubMed ID: 17101472
[TBL] [Abstract][Full Text] [Related]
7. Interaction between bcl-2 and P53 in neoplastic progression of basal cell carcinoma of the head and neck.
Staibano S; Lo Muzio L; Pannone G; Scalvenzi M; Salvatore G; Errico ME; Fanali S; De Rosa G; Piattelli A
Anticancer Res; 2001; 21(6A):3757-64. PubMed ID: 11911244
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation.
Stratigos AJ; Kapranos N; Petrakou E; Anastasiadou A; Pagouni A; Christofidou E; Petridis A; Papadopoulos O; Kokka E; Antoniou C; Georgala S; Katsambas AD
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):180-6. PubMed ID: 15752287
[TBL] [Abstract][Full Text] [Related]
9. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma.
Ansarin H; Daliri M; Soltani-Arabshahi R
Eur J Dermatol; 2006; 16(5):543-7. PubMed ID: 17101476
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53.
Abdelsayed RA; Guijarro-Rojas M; Ibrahim NA; Sangueza OP
J Cutan Pathol; 2000 Apr; 27(4):169-75. PubMed ID: 10774937
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical nuclear staining for p53, PCNA, Ki-67 and bcl-2 in different histologic variants of basal cell carcinoma.
Mateoiu C; Pirici A; Bogdan F
Rom J Morphol Embryol; 2011; 52(1 Suppl):315-9. PubMed ID: 21424069
[TBL] [Abstract][Full Text] [Related]
12. Basaloid/follicular hyperplasia overlying connective tissue/mesenchymal hamartomas simulating basal cell carcinomas.
Stashower ME; Smith K; Corbett D; Skelton HG
J Am Acad Dermatol; 2001 Dec; 45(6):886-91. PubMed ID: 11712034
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
[TBL] [Abstract][Full Text] [Related]
14. The expression of P53 protein and infection of human papilloma virus in conjunctival and eyelid neoplasms.
Reszec J; Sulkowski S
Int J Mol Med; 2005 Oct; 16(4):559-64. PubMed ID: 16142387
[TBL] [Abstract][Full Text] [Related]
15. CD10 expression in trichoepithelioma and basal cell carcinoma.
Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
[TBL] [Abstract][Full Text] [Related]
16. Proliferative characterization of basal-cell carcinoma and trichoepithelioma in small biopsy specimens.
Lum CA; Binder SW
J Cutan Pathol; 2004 Sep; 31(8):550-4. PubMed ID: 15268710
[TBL] [Abstract][Full Text] [Related]
17. Calcifications associated with basal cell carcinoma: prevalence, characteristics, and correlations.
Slodkowska EA; Cribier B; Peltre B; Jones DM; Carlson JA
Am J Dermatopathol; 2010 Aug; 32(6):557-64. PubMed ID: 20489568
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of cyclooxygenase-2 and p53 expression in skin tumors.
Kim KH; Park EJ; Seo YJ; Cho HS; Kim CW; Kim KJ; Park HR
J Dermatol; 2006 May; 33(5):319-25. PubMed ID: 16700663
[TBL] [Abstract][Full Text] [Related]
19. Pseudocarcinomatous hyperplasia with follicular differentiation overlying basal cell carcinoma.
Tuttle MS; Rosenberg AS; Winfield HL; Somach SC
Am J Dermatopathol; 2009 Aug; 31(6):557-60. PubMed ID: 19590419
[TBL] [Abstract][Full Text] [Related]
20. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
Sakiz D; Turkmenoglu TT; Kabukcuoglu F
Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]